Correction: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula: A randomized-controlled trial
Barbara Troesch, Johann Demmelmair, Martina Gimpfl, Christina Hecht, Goran Lakovic, Robert Roehle, Ljilja Sipka, Branka Trisic, Milica Vusurovic, Rotraut Schoop, Sznezana Zdjelar, Berthold Koletzko

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFolate and B Vitamins Research · Esophageal and GI Pathology · Fluoride Effects and Removal
After publication of this article [1], the authors discovered that the infant’s ‘whole blood folate’ concentrations in [1] were incorrectly referred to as ‘red cell folate’ throughout the manuscript.
Here, the authors have provided additional information to clarify these issues: The authors measured whole blood folate by using the microbiological assay, and have corrected for the dilution factor only. Measuring red cell folate would additionally require corrections for individual values of plasma folate and hematocrit but this was not performed in [1].
The authors have provided the following correction: All instances of ‘red cell folate’ in the text should be replaced with ‘whole blood folate’.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Troesch B, Demmelmair J, Gimpfl M, Hecht C, Lakovic G, Roehle R, et al. (2019) Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula: A randomized-controlled trial. P Lo S ONE 14(8): e 0216790. doi: 10.1371/journal.pone.0216790 31425504 PMC 6699731 · doi ↗ · pubmed ↗
